CESCA THERAPEUTICS INC. (65) | Business Operations (8)
Browse by Subcategory
Recent Contracts
-
Supply Agreement between BioHit Healthcare (Hefei) Co., Ltd. and ThermoGenesis Holdings, Inc. dated August 11, 2020
(Filed With SEC on August 14, 2020)
-
Voting Agreement between CARTXpress Bio, Inc. and Bay City Capital Fund V, L.P. and Bay City Capital Management V LLC
(Filed With SEC on March 26, 2019)
-
Voting Agreement, dated January 1, 2019, among CARTXpress Bio, Inc., ThermoGenesis Corp., Bay City Capital Fund V, L.P., and Bay City Capital Fund V Co-Investment Fund, L.P
(Filed With SEC on January 4, 2019)
-
Manufacturing and Supply Amending Agreement #2, effective as of July 13, 2020, between ThermoGenesis Holdings, Inc. and CBR Systems, Inc
(Filed With SEC on July 17, 2020)
-
Supply Agreement, effective as of April 22, 2020, between ThermoGenesis Corp. and ImmuneCyte Life Sciences Inc
(Filed With SEC on April 28, 2020)
-
Manufacturing and Supply Amending Agreement #1, effective as of March 16, 2020, between ThermoGenesis Corp. and CBR Systems, Inc
(Filed With SEC on March 20, 2020)
-
Supply Agreement, dated November 22, 2019, between ThermoGenesis Holdings, Inc. and ImmuneCyte Life Sciences Inc
(Filed With SEC on November 27, 2019)
-
Supply Agreement, dated as of August 30, 2019, between Corning Incorporated and Cesca Therapeutics Inc
(Filed With SEC on September 6, 2019)